Dr Daniel Hutcheson

Dr. Hutcheson, is a highly experienced pharmaceutical executive having held several senior positions in the pharmaceutical industry including contract research companies in Europe, Asia and the United States.

Most recently he has led portfolio strategy functions as advisor to Chief Scientific Officers including leading asset due-diligence, completed in-licensing partnerships for small molecules and long acting-injectable drug-delivery technology, partnering and alliance-management as well as outsourcing and grants-management.

His early research focused on animal models of central nervous system disorders leveraging his PhD in the behavioral pharmacology of Substance Use Disorder. He has led drug development programs for the treatment of Substance Use Disorder, and for psychiatric disease.